CORINNE CANAVERO: Open Payments
NPI 1386250298 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$911 in 37 payments from 11 companies in 2025. Trend: 2023 $673 · 2024 $2,091 · 2025 $911
Food & beverage: $911
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $242 |
| Boston Scientific Corporation | 5 | $218 |
| Saluda Medical Americas, Inc. | 6 | $168 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $78 |
| PFIZER INC. | 3 | $60 |
| Pacira Pharmaceuticals Incorporated | 2 | $35 |
| SCILEX PHARMACEUTICALS INC. | 2 | $31 |
| Globus Medical, Inc. | 1 | $26 |
| TerSera Therapeutics LLC | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: General - Pain Management, Evoke, UBRELVY, BOTOX, JOURNAVX, QULIPTA, NURTEC ODT, Iovera.
Industry payments across NV — which companies pay providers there.
